Cost-effectiveness of lung transplantation and its evolution: the Portuguese case
- 3 August 2013
- journal article
- research article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 15 (7) , 767-772
Abstract
Objectives We analyzed the costs and outcomes of lung transplant in Portugal and its evolution since it was first performed in 2000. Methods Data were collected for all patients waiting for transplant from 31 December 2000 until 31 December 2010 (n = 61). Patients waiting for transplant were used as the comparison group. We calculated the mean restricted survival time using the Kaplan–Meier estimation method. The time horizon was closed upon the death of the last surviving patient. Costs and consequences were discounted at 5 % per annum. We calculated the incremental cost-effectiveness ratio of transplant as compared to no transplant. Deterministic and probabilistic sensitivity analyses were performed. We tested volume-outcome effects using a parametric survival regression. Results The cost of lung transplantation was 77,223€ per QALY and 121,276€ per life-year. Assuming a 50,000€/QALY willingness-to-pay, lung transplant would be cost-effective with a 37 % probability. Survival improved substantially from 5.15 years over the 2001–2010 period to 6.94 years for the 2008–2010 period. When restricting our analysis to the 2008–2010 period, the cost-effectiveness ratio decreased to €79,016 per life-year gained and €69,241 per QALY. Survival was significantly associated with the number of procedures performed. Conclusion Although above commonly accepted cost-effectiveness thresholds, the economic value of lung transplant holds promise in Portugal due to the large improvement in survival over the 2001–2010 period. The life-threatening character of the motivating conditions, the absence of alternative treatment, and equity concerns should be also accounted for when assessing the “value for money” of lung transplant.Keywords
This publication has 9 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report—2012The Journal of Heart and Lung Transplantation, 2012
- Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-makingHealth Technology Assessment, 2009
- A Cost-Effectiveness and Cost-Utility Study of Lung TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Cost-Effectiveness of Lung Transplantation in Relation to Type of End-Stage Pulmonary DiseaseAmerican Journal of Transplantation, 2004
- Indications, patient selection and timing of referral for lung transplantationEuropean Respiratory Journal, 2003
- Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the LiteratureAnnals of Internal Medicine, 2002
- Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost‐effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancerHealth Economics, 2002
- An economic evaluation of lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Assessment of quality of life in lung transplantation using a simple generic toolThorax, 2001